Updated Jul 16, 2026
Nash Duane is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $17K.
Duane Nash serves as the Executive Chairman and Director of Immunic Inc., a clinical-stage biopharmaceutical company focused on developing therapies for chronic inflammatory and autoimmune diseases. He has been involved in the company through multiple SEC filings, indicating his active role in its governance.
| Role | Executive Chairman, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-06-13 | IMUX | IMMUNIC, INC. | P — Open-market purchase | 20.0K | $0.83 | $17K |
Duane Nash serves as the Executive Chairman and Director of Immunic Inc., a clinical-stage biopharmaceutical company focused on developing therapies for chronic inflammatory and autoimmune diseases. He has been involved in the company through multiple SEC filings, indicating his active role in its governance.…
Recorded transactions: 1 open-market purchases ($17K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Nash Duane profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.